نتائج البحث

A Novel and Simple Synthesis of Ethers of Hydroxypyridines with Hexafluoropropan-2-ol via Diazotization of Aminopyridines and Aminoquinolines Under Acid-Free Conditions.

• Authors : Filimonov, Victor D.¹ (AUTHOR) ; Sanzhiev, Aldar N.¹ (AUTHOR); Gulyaev, Roman O.¹ (AUTHOR)

• Source: Chemistry of Heterocyclic Compounds. Dec2022, Vol. 58 Issue 12, p721-726. 6p.

تفاصيل العنوان

Synthesis of Phosphoramidates Based on Aminopyridines.

• Authors : Krylov, A. S.¹ ; Piterskaya, Yu. L.¹; Gurzhiy, V. V.²

• Source: Russian Journal of General Chemistry. Oct2022, Vol. 92 Issue 10, p1912-1918. 7p.

تفاصيل العنوان

Synthesis of MAPA Reagents and 2-Alkyl(aryl)aminopyridines from 2-Bromopyridine Using the Goldberg Reaction.

• Authors : Comins, Daniel L.¹ (AUTHOR)

Subjects: *AMINOPYRIDINES; *METHANOLYSIS; *AMIDES

• Source: Molecules. Mar2022, Vol. 27 Issue 6, p1833. 10p.

تفاصيل العنوان

Diazotization of Aminopyridines in the Presence of Camphorsulfonic Acid. Synthesis and Some Properties of Pyridinyl Camphorsulfonates.

• Authors : Sanzhiev, A. N.¹ (AUTHOR); Krasnokutskaya, E. A.¹ (AUTHOR) ; Erin, K. D.¹ (AUTHOR)

• Source: Russian Journal of Organic Chemistry. Jun2021, Vol. 57 Issue 6, p922-929. 8p.

تفاصيل العنوان

STRUCTURE, QUANTUM CHEMICAL, HIRSHFELD SURFACES, AND ENERGY FRAMEWORK ANALYSIS OF SOME AMINOPYRIDINE DERIVATIVES.

• Authors : Sharma, R.¹; Kant, R.^1,2

• Source: Rasayan Journal of Chemistry. Jan-Mar2024, Vol. 17 Issue 1, p38-46. 9p.

تفاصيل العنوان

The case for publicly funding lorlatinib.

• Authors : Ashton JC; Department of Pharmacology and Toxicology, Otago School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.

Subjects: Lactams*/Lactams*/Lactams*/economics ; Pyrazoles*/Pyrazoles*/Pyrazoles*/economics ; Pyrazoles*/Pyrazoles*/Pyrazoles*/therapeutic use

• Source: The New Zealand medical journal [N Z Med J] 2024 Aug 23; Vol. 137 (1601), pp. 77-79. Date of Electronic Publication: 2024 Aug 23.Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand.

• Authors : Dajsakdipon T; Susiriwatananont T ...

Subjects: Piperazines*/Piperazines*/Piperazines*/administration & dosage ; Piperazines*/Piperazines*/Piperazines*/adverse effects ; Piperazines*/Piperazines*/Piperazines*/therapeutic use

• Source: BMC cancer [BMC Cancer] 2024 Aug 16; Vol. 24 (1), pp. 1018. Date of Electronic Publication: 2024 Aug 16.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Chidamide plus R-GDP for relapsed/refractory diffuse large B-cell lymphoma in patients ineligible for autologous transplantation: A prospective, single-arm, phase II study.

• Authors : Chen GL; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.

Subjects: Aminopyridines*/Aminopyridines*/Aminopyridines*/adverse effects ; Aminopyridines*/Aminopyridines*/Aminopyridines*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use

• Source: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (16), pp. e70142.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese women: Primary results from a phase 2 randomized study.

• Authors : Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China.; Tong Z

Subjects: Aminopyridines*/Aminopyridines*/Aminopyridines*/administration & dosage ; Aminopyridines*/Aminopyridines*/Aminopyridines*/therapeutic use ; Aminopyridines*/Aminopyridines*/Aminopyridines*/adverse effects

• Source: Cancer medicine [Cancer Med] 2024 Aug; Vol. 13 (15), pp. e7408.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK-positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinib.

• Authors : Sato Y; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.; Sato Y

Subjects: Organophosphorus Compounds*/Organophosphorus Compounds*/Organophosphorus Compounds*/therapeutic use ; Organophosphorus Compounds*/Organophosphorus Compounds*/Organophosphorus Compounds*/pharmacology ; Organophosphorus Compounds*/Organophosphorus Compounds*/Organophosphorus Compounds*/administration & dosage

• Source: Thoracic cancer [Thorac Cancer] 2024 Aug; Vol. 15 (23), pp. 1772-1775. Date of Electronic Publication: 2024 Jun 24.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان